NCT06911476View on ClinicalTrials.gov

From Inflammation to Remodelling Towards Personalized Diagnosis in Post-acute Sequelae of COVID-19

Not yet recruitingOBSERVATIONAL
Enrollment

60

Participants

Timeline

Start Date

May 31, 2025

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions
PASC Post Acute Sequelae of COVID 19Long COVIDLong Covid-19PASCFAPIFAPFibroblast Activation Protein InhibitorFibroblastRestrictive Lung Disease
All Listed Sponsors
collaborator

Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

OTHER

lead

University Medical Center Groningen

OTHER